PL2220256T3 - Sposób diagnozowania in vitro raka skóry - Google Patents

Sposób diagnozowania in vitro raka skóry

Info

Publication number
PL2220256T3
PL2220256T3 PL08851071T PL08851071T PL2220256T3 PL 2220256 T3 PL2220256 T3 PL 2220256T3 PL 08851071 T PL08851071 T PL 08851071T PL 08851071 T PL08851071 T PL 08851071T PL 2220256 T3 PL2220256 T3 PL 2220256T3
Authority
PL
Poland
Prior art keywords
skin cancer
vitro method
diagnosing skin
diagnosing
vitro
Prior art date
Application number
PL08851071T
Other languages
English (en)
Inventor
Nadem Soufir
Original Assignee
Hopitaux Paris Assist Publique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopitaux Paris Assist Publique filed Critical Hopitaux Paris Assist Publique
Publication of PL2220256T3 publication Critical patent/PL2220256T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL08851071T 2007-11-21 2008-11-21 Sposób diagnozowania in vitro raka skóry PL2220256T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0759193A FR2923841B1 (fr) 2007-11-21 2007-11-21 Procede in vitro de diagnostic du cancer de la peau
PCT/EP2008/066028 WO2009065944A1 (fr) 2007-11-21 2008-11-21 Procédé in vitro de diagnostic du cancer de la peau
EP08851071.4A EP2220256B1 (fr) 2007-11-21 2008-11-21 Procédé in vitro de diagnostic du cancer de la peau

Publications (1)

Publication Number Publication Date
PL2220256T3 true PL2220256T3 (pl) 2014-06-30

Family

ID=39523842

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08851071T PL2220256T3 (pl) 2007-11-21 2008-11-21 Sposób diagnozowania in vitro raka skóry

Country Status (9)

Country Link
US (1) US20110086805A1 (pl)
EP (1) EP2220256B1 (pl)
AU (1) AU2008327841B2 (pl)
DK (1) DK2220256T3 (pl)
ES (1) ES2449152T3 (pl)
FR (1) FR2923841B1 (pl)
PL (1) PL2220256T3 (pl)
PT (1) PT2220256E (pl)
WO (1) WO2009065944A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010131268A1 (en) * 2009-05-11 2010-11-18 Decode Genetics Ehf Genetic variants for basal cell carcinoma, squamous cell carcinoma and cutaneous melanoma
GB201520595D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
EP3383418B1 (en) * 2015-12-04 2021-10-20 Board of Regents, The University of Texas System Slc45a2 peptides for immunotherapy

Also Published As

Publication number Publication date
PT2220256E (pt) 2014-04-02
WO2009065944A1 (fr) 2009-05-28
FR2923841A1 (fr) 2009-05-22
EP2220256B1 (fr) 2014-01-01
FR2923841B1 (fr) 2011-04-29
ES2449152T3 (es) 2014-03-18
US20110086805A1 (en) 2011-04-14
EP2220256A1 (fr) 2010-08-25
AU2008327841A1 (en) 2009-05-28
DK2220256T3 (en) 2014-03-17
AU2008327841B2 (en) 2014-09-11

Similar Documents

Publication Publication Date Title
SI2173379T1 (sl) Sestavki in postopki za zdravljenje in diagnosticiranje raka
IL197111A0 (en) Anti-aging skin preparation
EP2129284A4 (en) IMAGING AND TOOLS FOR USE WITH MOBILE ORGANS
IL206748A (en) Molecular test for @cancer @ breast cancer @
SG10201604988YA (en) Methods and compositions for diagnostic use in cancer patients
IL210755A0 (en) Devices and methods for forming tracts in tissue
EP2222314A4 (en) METHOD AND MEANS FOR OBTAINING BRONCHORELAXATION
ZA201005248B (en) 4-pyridinone compounds and their use for cancer
IL194668A (en) A system for creating tiny truncated canals in the skin
EP2234626A4 (en) METHOD AND MEANS FOR PRODUCING BRONCHORELAXATION
GB201016411D0 (en) In vivo imaging method for cancer
ZA201106240B (en) Method and means for producing tissues and tissues obtained
IL217748A0 (en) Methods and compositions for diagnostics use in cancer patients
IL238394A0 (en) Cancer treatment method
PL2220256T3 (pl) Sposób diagnozowania in vitro raka skóry
GB0707556D0 (en) Treatment for cancer
GB0618429D0 (en) Cancer test
GB0718748D0 (en) Diagnostic method
GB0718226D0 (en) Method of in vitro diagnosing
GB0723336D0 (en) Method of in vitro diagnosing
GB0704205D0 (en) Emotional spech synthesis
GB0813352D0 (en) Cancer treatment and test
IL206051A0 (en) Methods of diagnosing cancer
GB0519705D0 (en) An in vitro skin tolerance testing system
IL192875A0 (en) Marker and method for cancer diagnosis